Saadallah Ramadan

Associate Professor Saad Ramadan is the Director of MR Research and NIF Node co-director of the University of Newcastle – HMRI Imaging Centre. In this role, he has primary responsibility of the operation of our state-of-the-art 3T Prisma scanner and its advanced auxiliary technology. He also supervises a staff of four, including two MRI radiographers, an MRI Scientist and a NIF Fellow. He writes business cases for personnel support, strategy documents for equipment leading to business cases, communication with potential Imaging Centre researchers with diverse backgrounds and NIF reporting requirements. He is also responsible for the oversight for all research processes in the Imaging Centre, from setting the overall strategy, reviewing the governance procedures, revising flows through the Imaging Centre and building strategic alliances. In addition to these tasks, A/Prof Ramadan also runs an active research program and is considered one of Australia’s leading experts in advanced magnetic resonance spectroscopy and its clinical translation. A/Prof Ramadan currently supervises seven local and international PHD students, with a focus on translational projects in multiple sclerosis (MS), where advanced MR tools such as spectroscopy, diffusion, volumetrics, chemical exchange saturation transfer and susceptibility weighted imaging are used. He established novel neuro-metabolic signatures for disease modifying therapies and evaluated novel MR metrics for a newly developed neutraceuticals designed to combat MS fatigue funded by Multiple Sclerosis Research Australia. He recently received funding from Biogen to study white matter integrity and recovery in MS patients. A Prof Ramadan is also a national leader in the application of clinical and advanced spectroscopic in vivo techniques to many pathologies including myeloma, bone marrow, multiple sclerosis, glioblastoma, prostate, breast cancer and muscle. Other research interest of A/Prof Ramadan include the role of MRI in gastric emptying and placental and foetal brain imaging. He also has extensive industry collaborations, including Siemens Healthineers and French imaging company (Olea Medical). The HMRI Imaging Centre addresses unmet needs for regional Australia and rural communities and facilitates important research challenges. Additionally, in collaboration with Siemens Healthineers and Wollotuka Institute, Indigenous Training Fellowships in engineering or imaging healthcare will be undertaken at the Imaging Centre.

Ingrid Burvenich

Ingrid is a senior post-doctoral fellow at the Tumour Targeting Program of Prof Scott, ONJCRI. Dr Burvenich is a highly experienced researcher in molecular imaging and biology, and has extensive experience in animal models of disease, as well as in targeted therapeutics and cancer biology. She also has an extensive experience in large collaborative projects, animal ethics, has an excellent track record in grant success (NHMRC, Philanthropic groups) and in industry engagement. She has been pivotally involved in the preclinical development of bioimaging therapeutic antibodies translating these to Phase I bioimaging studies. In the past five years three of these antibodies have entered phase I bioimaging human trials (NCT01220999, NCT02252211, NCT04297748) and she has been the first author on nine publications.

Muneer Ahamed

Muneer Ahamed obtained his Masters in Chemistry in India and worked as a senior research chemist at GVKBio and Jubilant Discovery Center (India) in CNS Drug Discovery. He then moved to The University of Sydney, Australia to pursue his PhD (Chemistry) under supervision of Prof. Matthew H. Todd and obtained in 2011. He then moved to Europe and worked as a post-doctoral fellow with Prof. Guy Bormans (KU Leuven, Belgium) developing small molecule tracers for PET imaging until late-2016. Subsequently, he was at Flinders University, Adelaide, in the lab of Prof. Colin L Raston (AO FAA FRACI FRSC) and then at Centre for Advanced Imaging, The University of Queensland with Prof. Kris Thurecht. In November 2021, he joined SAHMRI, Adelaide as a Senior Research Fellow. His research interests include developing new tracers for neuro-PET imaging of endocannabinoid system, epigenetics, ion channels and neuroinflammation.

John Magnussen

Professor Magnussen graduated in Medicine from the University of New South Wales (UNSW), before completing a PhD in Nuclear Medicine and Biomedical Engineering, also at UNSW. He qualified in Radiology from Royal Prince Alfred Hospital (RPAH) where he remained for several years as Director of Research and Staff Specialist Radiologist. During this time, John worked both in diagnostic and interventional radiology at RPAH and at several major Private Hospitals. In 2010, he was appointed Professor of Radiology at Macquarie University and was pivotal in establishing Macquarie Medical Imaging, dedicating himself to establishing a unique standard of excellence at the University Hospital practice. He has completed advanced training in CT Coronary Angiography and has presented at numerous international meetings, in basic science and clinical research.

Research interests

  • Neuroradiology, including advanced imaging techniques such as MRS, qMRS, fMRI, qSWI, ASL
  • Cardiac imaging
  • Back pain imaging and management
  • Archaeology
  • Paleontology

Andrew Scott

Prof. Andrew Scott leads the Tumour Targeting Program at the Olivia Newton-John Cancer Research Institute and co-Director, Centre for Research Excellence in Brain Tumours; is Director, Department of Molecular Imaging and Therapy, Austin Health; and is Professor, La Trobe University University of and Melbourne. His clinical and research interests are focused on  developing innovative strategies for targeted therapy of cancer (particularly with monoclonal antibodies), molecular imaging in oncology, and global advocacy in Oncology and Nuclear Medicine. His laboratory has been involved in the preclinical development and first-in-man trials of numerous recombinant antibodies in cancer patients, and seven antibodies developed in his laboratory have been licenced to Biotech and Pharma companies, and have entered Phase I/II/III trials. He has published 398 peer reviewed papers and 27 book chapters, is an inventor on 22 patents, and is a founder of a biotech company. Prof. Scott is a member of the Strategic Advisory Committee for the National Imaging Facility, a member of the Scientific Committee of ARTnet, and Federal Council member of the Australian and New Zealand Society of Nuclear Medicine. In 2017 he was awarded Member (AM) in the General Division of the Order of Australia, and elected a Fellow of the Australian Academy of Health and Medical Sciences.

Andrew Dwyer

Andrew is currently the Director of the Clinical & Research Imaging Centre (CRIC) and Head of Imaging at the South Australian Health and Medical Research Institute (SAHMRI). He graduated in 2001 with the Frank S. Hone Memorial prize for medicine, the William Gardner prize for surgery and the University of Adelaide Lister medal. He was admitted as a fellow of the Royal Australian and New Zealand College of Radiologists in 2009 after fellowship in MRI and was awarded the RANZCR 2016 Bill Hare Fellowship.

His interests include:

  • Advanced clinical and research MRI applications.
  • Functional neuroimaging.
  • Cardiac CT and MRI (ANZCTCA and ANZCMR accredited).
  • Orthopaedic and sports medicine.

Robert Brkljaca

Dr Brkljača obtained his PhD in Chemistry at RMIT University and has extensive experience in Nuclear Magnetic Resonance. He is the facility manager and imaging support scientist at Alfred Research Alliance-Monash Biomedical Imaging (ARA-MBI), and assists researchers using the 9.4T MRI system including training, troubleshooting, data analysis, and imaging procedures.

Sjoerd Vos

Dr Sjoerd Vos is a Senior Research Fellow at the University of Western Australia, where he is the National Imaging Facility (NIF) Fellow overseeing the new 3T human MRI scanner that is being installed in the Western Australian NIF node. This new scanner is the only research-dedicated MRI scanner in WA, and intended to facilitate high-end in vivo human imaging for the state.

Sjoerd graduated from the VU University Amsterdam with a BSc and MSc in Medical Physics, before beginning a PhD in diffusion MRI at the Image Sciences Institute at the University Medical Center Utrecht, also in the Netherlands. Upon completion, Sjoerd joined University College London in March 2014, working between UCL’s Centre for Medical Image Computing (CMIC) and the epilepsy imaging group. In September 2019, he started as lecturer in Quantitative Neuroradiology, with a joint appointment between CMIC and the Neuroradiology department at Queen Square where he worked on integrating quantitative neuroimaging techniques into routine radiological practice. This resulted in integrating quantitative imaging and analyses in dementia diagnosis and, for epilepsy, hippocampal lesion detection and characterisation. His ongoing collaborations with UCL involve improved surgical planning for epilepsy surgery using white matter fibre tractography, and automated image quality control of neuroimaging data.

Ekaterina Salimova

Dr. Ekaterina (Caty) Salimova completed her PhD at the University of Fribourg (Switzerland), followed by extensive postdoctoral training at the European Molecular Biology Laboratory (EMBL, Italy) with a particular focus on the signalling pathways implicated in heart function, repair, and regeneration. During this period, she gained significant expertise in murine microsurgery and ultrasound imaging. In 2012 Caty moved to Monash University as a research fellow at the Australian Regenerative Medicine Institute (ARMI) where she continued her investigations into the genetics of cardiovascular regeneration in close collaboration with the Monash Biomedical Imaging (MBI) facility. She joined MBI in 2018 as a preclinical scientist as an expert in small animal sonography and procedures. In 2020, in collaboration with CSIRO she was appointed to run the MRI-guided Focussed Ultrasound (MRgFUS) at MBI. Caty is currently involved in running multiple preclinical imaging projects, including developing cardiac MRI and assisting with molecular PET/SPECT studies. Her main research interests are in the development of techniques to image cardiovascular disease and using MRgFUS to investigate targeted delivery of new neuro-oncology therapeutics to brain tumours.

Angela Walls

Angela Walls is the Chief Technologist at the Clinical and Research Imaging Centre, at the South Australian Health and Medical Research Centre (SAHMRI).  Here, she supports South Australian Researchers through the planning and development of preclinical imaging projects through to translational research.  A variety of 3T MRI examinations are performed at CRIC, with a current focus on Neurologic and Cardiac work.   Angela completed her Masters degree in Medical Science in 2006 through the University of Newcastle, and prior to her position at SAHMRI was Head of MRI at Flinders Medical Centre, Adelaide.

Privacy Settings
Youtube
Vimeo
Google Maps